Sedating Effects of Dexmedetomidine Versus Midazolam in Agitated Patients Undergoing Weaning in Icu.

Agitation on Recovery From Sedation Clinical Trial

Official title:
Sedating Effects of Dexmedetomidine Versus Midazolam in Agitated Patients Undergoing Weaning in ICU

Status Not yet recruiting

Clinical Trial Summary

Comparison of sedating effect of dexmedetomidine and midazolam for sedation in icu patients who put on mechanical ventilation and undergoing weaning. Selction of better sedating agent minimises the drug related side effects like respiratory depression but also helps in weaning in shorter time,give hemodynamic stability and reduce morbidity and mortality in icu..

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Agitation on Recovery From Sedation
Psychomotor Agitation

Clinical Trial Details

NCT number	NCT05264077
Study type	Interventional
Source	Sheikh Zayed Medical College
Contact	Momal j Khan
Phone	03116660901
Email	momal.rehan56@gmail.com
Status	Not yet recruiting
Phase	Early Phase 1
Start date	June 1, 2022
Completion date	March 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04184141` - Preoperative Use of Alprazolam and Hydroxyzine in Anxiety	Phase 4
Completed	`NCT05451381` - Vasopressor Requirements Depends on Sedation Strategy	N/A
Completed	`NCT04270331` - Assessment and Management of Pain, Agitation, Delirium and Sleep Deprivation (PADS) in ICU by PADS Protocol, Thailand	N/A